301206 三元生物
按盤價 
27.000 +3.370 (+14.262%)
27.000 +3.370 (+14.262%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.196 | 2.094 | 2.325 | 1.223 | 5.778 |
| 總資產報酬率 ROA (%) | 1.133 | 1.982 | 2.184 | 1.157 | 5.033 |
| 投入資產回報率 ROIC (%) | 1.174 | 2.037 | 2.233 | 1.177 | 5.209 | 邊際利潤分析 |
| 銷售毛利率 (%) | 17.594 | 16.118 | 11.106 | 3.050 | 14.055 |
| 營業利潤率 (%) | 13.408 | 16.172 | 17.947 | 11.709 | 27.567 |
| 息稅前利潤/營業總收入 (%) | 13.953 | 15.451 | 16.577 | 10.205 | 18.896 |
| 淨利潤/營業總收入 (%) | 11.756 | 14.056 | 14.722 | 11.208 | 24.253 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 57.847 | 32.056 | 14.140 | -87.357 | 49.978 |
| 價值變動淨收益/利潤總額(%) | 43.236 | 66.282 | 84.692 | 189.989 | 46.829 |
| 營業外收支淨額/利潤總額(%) | 0.036 | 0.368 | 0.203 | 0.566 | -1.140 | 償債能力分析 |
| 流動比率 (X) | 7.231 | 18.340 | 13.904 | 1.435 | 3.226 |
| 速動比率 (X) | 6.366 | 16.860 | 13.319 | 0.970 | 2.759 |
| 資產負債率 (%) | 6.460 | 4.067 | 6.535 | 5.666 | 5.116 |
| 帶息債務/全部投入資本 (%) | 0.399 | 0.419 | 1.990 | 3.433 | 2.212 |
| 股東權益/帶息債務 (%) | 24,616.844 | 23,399.675 | 4,850.041 | 2,783.689 | 4,380.713 |
| 股東權益/負債合計 (%) | 1,448.039 | 2,358.828 | 1,430.123 | 1,664.855 | 1,854.666 |
| 利息保障倍數 (X) | 25.832 | -19.783 | -11.787 | -6.498 | -2.260 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 33.719 | 56.192 | 49.886 | 46.746 | 51.305 |
| 存貨周轉天數 (天) | 95.889 | 104.827 | 70.167 | 74.750 | 64.836 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 08/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
